161 related articles for article (PubMed ID: 33236704)
1. Providing Ancillary Care in Clinical Research: A Case of Diffuse Large B-Cell Lymphoma during a Malaria Vaccine Trial in Equatorial Guinea.
Manock SR; Mtoro A; Urbano Nsue Ndong V; Olotu A; Chemba M; Sama Roca AE; Eburi E; García GA; Cortes Falla C; Niemczura de Carvalho J; Contreras J; Saturno B; Riocalo JD; Nze Mba JL; Koka R; Lee ST; Menon H; Church LWP; Ayekaba MO; Billingsley PF; Abdulla S; Richie TL; Hoffman SL
Am J Trop Med Hyg; 2020 Nov; 104(2):695-699. PubMed ID: 33236704
[TBL] [Abstract][Full Text] [Related]
2. The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa.
Billingsley PF; Maas CD; Olotu A; Schwabe C; García GA; Rivas MR; Hergott DEB; Daubenberger C; Saverino E; Chaouch A; Embon O; Chemba M; Nyakarungu E; Hamad A; Cortes C; Schindler T; Mpina M; Mtoro A; Sim BKL; Richie TL; McGhee K; Tanner M; Obiang Lima GM; Abdulla S; Hoffman SL; Ayekaba MO
Am J Trop Med Hyg; 2020 Sep; 103(3):947-954. PubMed ID: 32458790
[TBL] [Abstract][Full Text] [Related]
3. Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men.
Olotu A; Urbano V; Hamad A; Eka M; Chemba M; Nyakarungu E; Raso J; Eburi E; Mandumbi DO; Hergott D; Maas CD; Ayekaba MO; Milang DN; Rivas MR; Schindler T; Embon OM; Ruben AJ; Saverino E; Abebe Y; Kc N; James ER; Murshedkar T; Manoj A; Chakravarty S; Li M; Adams M; Schwabe C; Segura JL; Daubenberger C; Tanner M; Richie TL; Billingsley PF; Lee Sim BK; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2018 Jan; 98(1):308-318. PubMed ID: 29141739
[TBL] [Abstract][Full Text] [Related]
4. A paradigm for Africa-centric vaccine development in Equatorial Guinea.
Billingsley PF; Richie TL; Abdulla S; Ondo'o Ayekaba M; Daubenberger CA; Garcia GA; Hoffman SL
Trends Parasitol; 2024 May; 40(5):362-366. PubMed ID: 38582683
[TBL] [Abstract][Full Text] [Related]
5. Community perceptions of a malaria vaccine in the Kintampo districts of Ghana.
Febir LG; Asante KP; Dzorgbo DB; Senah KA; Letsa TS; Owusu-Agyei S
Malar J; 2013 May; 12():156. PubMed ID: 23651533
[TBL] [Abstract][Full Text] [Related]
6. Towards a malaria vaccine for Papua New Guinea.
Reeder JC
P N G Med J; 2001; 44(1-2):17-23. PubMed ID: 12418674
[TBL] [Abstract][Full Text] [Related]
7. Determinants of delay in malaria care-seeking behaviour for children 15 years and under in Bata district, Equatorial Guinea.
Romay-Barja M; Cano J; Ncogo P; Nseng G; Santana-Morales MA; Valladares B; Riloha M; Benito A
Malar J; 2016 Mar; 15():187. PubMed ID: 27036554
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea.
Nchama VUNN; Said AH; Mtoro A; Bidjimi GO; Owono MA; Maye ERM; Mangue MEO; Okomo GNN; Pasialo BEN; Ondo DM; Lopez MA; Mochomuemue FL; Obono MO; Besaha JCM; Chuquiyauri R; Jongo SA; Kamaka K; Kibondo UA; Athuman T; Falla CC; Eyono JNM; Smith JM; García GA; Raso J; Nyakarungu E; Mpina M; Schindler T; Daubenberger C; Lemiale L; Billingsley PF; Sim BKL; Richie TL; Church LWP; Olotu A; Tanner M; Hoffman SL; Abdulla S
Malar J; 2021 Jul; 20(1):322. PubMed ID: 34284778
[TBL] [Abstract][Full Text] [Related]
10. The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea.
Manock SR; Nsue VU; Olotu A; Mpina M; Nyakarungu E; Raso J; Mtoro A; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema R; Riyahi P; Schindler T; Daubenberger C; Church LWP; Billingsley PF; Richie TL; Abdulla S; Hoffman SL
Trans R Soc Trop Med Hyg; 2022 Aug; 116(8):745-749. PubMed ID: 35394038
[TBL] [Abstract][Full Text] [Related]
11. Community perceptions of malaria and vaccines in two districts of Mozambique.
Bingham A; Gaspar F; Lancaster K; Conjera J; Collymore Y; Ba-Nguz A
Malar J; 2012 Nov; 11():394. PubMed ID: 23186030
[TBL] [Abstract][Full Text] [Related]
12. Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation.
Moorthy V; Reed Z; Smith PG;
Vaccine; 2007 Jul; 25(28):5115-23. PubMed ID: 17577487
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of anemia and associated factors in children living in urban and rural settings from Bata District, Equatorial Guinea, 2013.
Ncogo P; Romay-Barja M; Benito A; Aparicio P; Nseng G; Berzosa P; Santana-Morales MA; Riloha M; Valladares B; Herrador Z
PLoS One; 2017; 12(5):e0176613. PubMed ID: 28467452
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.
Mahmoudi S; Keshavarz H
Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979
[TBL] [Abstract][Full Text] [Related]
15. A review of malaria vaccine clinical projects based on the WHO rainbow table.
Schwartz L; Brown GV; Genton B; Moorthy VS
Malar J; 2012 Jan; 11():11. PubMed ID: 22230255
[TBL] [Abstract][Full Text] [Related]
16. Good news in malaria control... now what?
Steketee RW
Am J Trop Med Hyg; 2009 Jun; 80(6):879-80. PubMed ID: 19478241
[No Abstract] [Full Text] [Related]
17. Trends in parasite prevalence following 13 years of malaria interventions on Bioko island, Equatorial Guinea: 2004-2016.
Cook J; Hergott D; Phiri W; Rivas MR; Bradley J; Segura L; Garcia G; Schwabe C; Kleinschmidt I
Malar J; 2018 Feb; 17(1):62. PubMed ID: 29402288
[TBL] [Abstract][Full Text] [Related]
18. Interpreting challenge data from early phase malaria blood stage vaccine trials.
Good MF; Miller LH
Expert Rev Vaccines; 2018 Mar; 17(3):189-196. PubMed ID: 29382292
[TBL] [Abstract][Full Text] [Related]
19. The malaria vaccine development program in Papua New Guinea.
Genton B; Anders RF; Alpers MP; Reeder JC
Trends Parasitol; 2003 Jun; 19(6):264-70. PubMed ID: 12798084
[TBL] [Abstract][Full Text] [Related]
20. Malaria determining risk factors at the household level in two rural villages of mainland Equatorial Guinea.
Guerra M; de Sousa B; Ndong-Mabale N; Berzosa P; Arez AP
Malar J; 2018 May; 17(1):203. PubMed ID: 29776367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
